Adenosine A2b receptor

Class

Adenosine A2b receptor antagonist (small molecule)

Pathway

Blocks adenosine-mediated immunosuppression in the tumor microenvironment

The adenosine A2b receptor is a cell-surface signaling protein belonging to the G protein-coupled receptor family, activated by adenosine, a small molecule that accumulates when tissue is stressed, injured, or oxygen-starved. Solid tumors often create exactly these conditions, generating unusually high local adenosine concentrations. Because the A2b receptor has comparatively low affinity for adenosine, it becomes engaged mainly under this rare, high-adenosine setting, distinguishing it from related adenosine receptor subtypes that respond at lower concentrations. When activated in the tumor microenvironment, A2b signaling dampens the activity of immune cells that would otherwise attack cancer cells, and it favors the recruitment of immune cell types that support tumor growth. Blocking this receptor with a small-molecule antagonist is intended to remove that brake on immune surveillance, allowing T cells and other effector immune populations to act against the tumor. This mechanism is being explored broadly in oncology, often alongside other immune-modulating approaches, on the premise that reducing adenosine-driven suppression can make tumors more visible and vulnerable to the immune system. The rationale rests on established biology of adenosine as a stress signal and immune regulator rather than on any single disease being definitively linked to this pathway.